What is Stoke Therapeutics, Inc.'s accounts receivable?

Stoke Therapeutics, Inc. (STOK) reported accounts receivable of $4.45M in Q1 2026.

How has Stoke Therapeutics, Inc.'s accounts receivable changed year-over-year?

Stoke Therapeutics, Inc.'s accounts receivable increased by 235.9% year-over-year, from $1.33M to $4.45M.

What does accounts receivable mean?

Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.

Stoke Therapeutics, Inc. STOK Accounts Receivable

Accounts Receivable at other companies

Jazz PharmaceuticalsJAZZ

$836.3M+28.1%

Harmony Biosciences Holdings, Inc.HRMY

$108.22M+2.1%

Nuvation BioNUVB

$22.72M+5,456%

Sarepta Therapeutics, Inc.SRPT

$394.82M-40.1%

Septerna, Inc.SEPN

$10.84M+4,237%

uniQureQURE

$3.56M—

Other financials

Income statement

See full

Revenue$6.2M-96.1%

Operating income-$53.4M-148%

Net income-$50.0M-144%

EPS (diluted)-$0.79-142%

Balance sheet

See full

Cash & equivalents$155.7M-43.4%

Total debt$3.4M-42.5%

Total equity$394.9M+12.8%

Total assets$443.3M+8.9%

Cash flow

See full

Operating cash flow-$60.6M-146%

CapEx$353.0K+132%

Free cash flow-$60.9M-146%

Valuation

See full

Market cap$1.94B+436%

Enterprise value$1.79B+1,855%

P/S60.4×+58.5×

Profitability

See full

Operating margin-577.5%-597pp

Net margin-529.2%-556pp

FCF margin36.2%+18.4pp

Returns & leverage

See full

Return on equity-45.6%-66.1pp

Debt / equity0×0.0×

Current ratio9×+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s accounts receivable?: Stoke Therapeutics, Inc. (STOK) reported accounts receivable of $4.45M in Q1 2026.
How has Stoke Therapeutics, Inc.'s accounts receivable changed year-over-year?: Stoke Therapeutics, Inc.'s accounts receivable increased by 235.9% year-over-year, from $1.33M to $4.45M.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.